Piper Sandler Maintains Overweight on Helmerich & Payne, Raises Price Target to $43

Helmerich & Payne, Inc.

Helmerich & Payne, Inc.

HP

0.00

Piper Sandler analyst Derek Podhaizer maintains Helmerich & Payne (NYSE: HP) with a Overweight and raises the price target from $41 to $43.